{"id":5953,"date":"2022-09-30T15:32:00","date_gmt":"2022-09-30T13:32:00","guid":{"rendered":"https:\/\/m2apartners.cz\/mdr-for-the-third-time-clinical-trials\/"},"modified":"2025-03-27T17:04:57","modified_gmt":"2025-03-27T16:04:57","slug":"mdr-for-the-third-time-clinical-trials","status":"publish","type":"post","link":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/","title":{"rendered":"MDR for the third time – clinical trials"},"content":{"rendered":"\n

In the printed version of Medical Tribune, our third article focused on the MDR, the new EU Medical Device Regulation, which will come into force on 26 May 2020, was published.This time, we focus on some aspects of clinical trials, especially in relation to devices that have been proven by long-term use in practice. The full article is available here: https:\/\/www.tribune.cz\/clanek\/44674-mdr-potreti-klinicka-hodnoceni<\/a> <\/p>\n","protected":false},"excerpt":{"rendered":"

In the printed version of Medical Tribune, our third article focused on the MDR, the new EU Medical Device Regulation, which will come into force on 26 May 2020, was published.This time, we focus on some aspects of clinical trials, especially in relation to devices that have been proven by long-term use in practice. The […]<\/p>\n","protected":false},"author":1,"featured_media":5524,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[320,357],"tags":[358,360,511],"class_list":["post-5953","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-medical-devices","tag-eu-legislation","tag-mdr-en","tag-pharmaceutical-industry"],"yoast_head":"\nMDR for the third time - clinical trials - m2apartners.cz<\/title>\n<meta name=\"description\" content=\"In the printed version of Medical Tribune, our third article focused on the MDR, the new EU Medical Device Regulation, which will come into force on 26 May 2020, was published.This time, we focus on some aspects of clinical trials, especially in relation to devices that have been proven by long-term use in practice. The full article is available here: https:\/\/www.tribune.cz\/clanek\/44674-mdr-potreti-klinicka-hodnoceni\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MDR for the third time - clinical trials - m2apartners.cz\" \/>\n<meta property=\"og:description\" content=\"In the printed version of Medical Tribune, our third article focused on the MDR, the new EU Medical Device Regulation, which will come into force on 26 May 2020, was published.This time, we focus on some aspects of clinical trials, especially in relation to devices that have been proven by long-term use in practice. The full article is available here: https:\/\/www.tribune.cz\/clanek\/44674-mdr-potreti-klinicka-hodnoceni\" \/>\n<meta property=\"og:url\" content=\"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"m2apartners.cz\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-30T13:32:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-27T16:04:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/m2apartners.cz\/wp-content\/uploads\/2022\/09\/3-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"940\" \/>\n\t<meta property=\"og:image:height\" content=\"788\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin3645\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin3645\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/\"},\"author\":{\"name\":\"admin3645\",\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/#\\\/schema\\\/person\\\/2737d6d592b954976f2a3fdcb4e8248e\"},\"headline\":\"MDR for the third time – clinical trials\",\"datePublished\":\"2022-09-30T13:32:00+00:00\",\"dateModified\":\"2025-03-27T16:04:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/\"},\"wordCount\":73,\"publisher\":{\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/m2apartners.cz\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/3-2.png\",\"keywords\":[\"EU legislation\",\"MDR\",\"pharmaceutical industry\"],\"articleSection\":[\"Articles\",\"Medical devices\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/\",\"name\":\"MDR for the third time - clinical trials - m2apartners.cz\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/m2apartners.cz\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/3-2.png\",\"datePublished\":\"2022-09-30T13:32:00+00:00\",\"dateModified\":\"2025-03-27T16:04:57+00:00\",\"description\":\"In the printed version of Medical Tribune, our third article focused on the MDR, the new EU Medical Device Regulation, which will come into force on 26 May 2020, was published.This time, we focus on some aspects of clinical trials, especially in relation to devices that have been proven by long-term use in practice. The full article is available here: https:\\\/\\\/www.tribune.cz\\\/clanek\\\/44674-mdr-potreti-klinicka-hodnoceni\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/m2apartners.cz\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/3-2.png\",\"contentUrl\":\"https:\\\/\\\/m2apartners.cz\\\/wp-content\\\/uploads\\\/2022\\\/09\\\/3-2.png\",\"width\":940,\"height\":788,\"caption\":\"Klinick\u00e1 hodnocen\u00ed\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/mdr-for-the-third-time-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MDR for the third time - clinical trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/\",\"name\":\"m2apartners.cz\",\"description\":\"We focus on providing legal services to clients in the pharmaceutical and medical device industries, in corporate matters, in connection with the setting up of internal processes, in matters of zoning and construction law proceedings, in general practice, especially general contract, real estate, family and employment law.\",\"publisher\":{\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/#organization\",\"name\":\"M2A Partners\",\"url\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/m2apartners.cz\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-cropped-FAV_512x512.png\",\"contentUrl\":\"https:\\\/\\\/m2apartners.cz\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/cropped-cropped-FAV_512x512.png\",\"width\":512,\"height\":512,\"caption\":\"M2A Partners\"},\"image\":{\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/m2apartners.cz\\\/en\\\/#\\\/schema\\\/person\\\/2737d6d592b954976f2a3fdcb4e8248e\",\"name\":\"admin3645\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/baf40bb2dd82590384e4496ea9a16e5723a6284ec7fb445ad629f19905b6c337?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/baf40bb2dd82590384e4496ea9a16e5723a6284ec7fb445ad629f19905b6c337?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/baf40bb2dd82590384e4496ea9a16e5723a6284ec7fb445ad629f19905b6c337?s=96&d=mm&r=g\",\"caption\":\"admin3645\"},\"sameAs\":[\"https:\\\/\\\/m2apartners.cz\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MDR for the third time - clinical trials - m2apartners.cz","description":"In the printed version of Medical Tribune, our third article focused on the MDR, the new EU Medical Device Regulation, which will come into force on 26 May 2020, was published.This time, we focus on some aspects of clinical trials, especially in relation to devices that have been proven by long-term use in practice. The full article is available here: https:\/\/www.tribune.cz\/clanek\/44674-mdr-potreti-klinicka-hodnoceni","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"MDR for the third time - clinical trials - m2apartners.cz","og_description":"In the printed version of Medical Tribune, our third article focused on the MDR, the new EU Medical Device Regulation, which will come into force on 26 May 2020, was published.This time, we focus on some aspects of clinical trials, especially in relation to devices that have been proven by long-term use in practice. The full article is available here: https:\/\/www.tribune.cz\/clanek\/44674-mdr-potreti-klinicka-hodnoceni","og_url":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/","og_site_name":"m2apartners.cz","article_published_time":"2022-09-30T13:32:00+00:00","article_modified_time":"2025-03-27T16:04:57+00:00","og_image":[{"width":940,"height":788,"url":"https:\/\/m2apartners.cz\/wp-content\/uploads\/2022\/09\/3-2.png","type":"image\/png"}],"author":"admin3645","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin3645"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/"},"author":{"name":"admin3645","@id":"https:\/\/m2apartners.cz\/en\/#\/schema\/person\/2737d6d592b954976f2a3fdcb4e8248e"},"headline":"MDR for the third time – clinical trials","datePublished":"2022-09-30T13:32:00+00:00","dateModified":"2025-03-27T16:04:57+00:00","mainEntityOfPage":{"@id":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/"},"wordCount":73,"publisher":{"@id":"https:\/\/m2apartners.cz\/en\/#organization"},"image":{"@id":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/m2apartners.cz\/wp-content\/uploads\/2022\/09\/3-2.png","keywords":["EU legislation","MDR","pharmaceutical industry"],"articleSection":["Articles","Medical devices"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/","url":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/","name":"MDR for the third time - clinical trials - m2apartners.cz","isPartOf":{"@id":"https:\/\/m2apartners.cz\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/m2apartners.cz\/wp-content\/uploads\/2022\/09\/3-2.png","datePublished":"2022-09-30T13:32:00+00:00","dateModified":"2025-03-27T16:04:57+00:00","description":"In the printed version of Medical Tribune, our third article focused on the MDR, the new EU Medical Device Regulation, which will come into force on 26 May 2020, was published.This time, we focus on some aspects of clinical trials, especially in relation to devices that have been proven by long-term use in practice. The full article is available here: https:\/\/www.tribune.cz\/clanek\/44674-mdr-potreti-klinicka-hodnoceni","breadcrumb":{"@id":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/#primaryimage","url":"https:\/\/m2apartners.cz\/wp-content\/uploads\/2022\/09\/3-2.png","contentUrl":"https:\/\/m2apartners.cz\/wp-content\/uploads\/2022\/09\/3-2.png","width":940,"height":788,"caption":"Klinick\u00e1 hodnocen\u00ed"},{"@type":"BreadcrumbList","@id":"https:\/\/m2apartners.cz\/en\/mdr-for-the-third-time-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/m2apartners.cz\/en\/"},{"@type":"ListItem","position":2,"name":"MDR for the third time - clinical trials"}]},{"@type":"WebSite","@id":"https:\/\/m2apartners.cz\/en\/#website","url":"https:\/\/m2apartners.cz\/en\/","name":"m2apartners.cz","description":"We focus on providing legal services to clients in the pharmaceutical and medical device industries, in corporate matters, in connection with the setting up of internal processes, in matters of zoning and construction law proceedings, in general practice, especially general contract, real estate, family and employment law.","publisher":{"@id":"https:\/\/m2apartners.cz\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/m2apartners.cz\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/m2apartners.cz\/en\/#organization","name":"M2A Partners","url":"https:\/\/m2apartners.cz\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/m2apartners.cz\/en\/#\/schema\/logo\/image\/","url":"https:\/\/m2apartners.cz\/wp-content\/uploads\/2025\/03\/cropped-cropped-FAV_512x512.png","contentUrl":"https:\/\/m2apartners.cz\/wp-content\/uploads\/2025\/03\/cropped-cropped-FAV_512x512.png","width":512,"height":512,"caption":"M2A Partners"},"image":{"@id":"https:\/\/m2apartners.cz\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/m2apartners.cz\/en\/#\/schema\/person\/2737d6d592b954976f2a3fdcb4e8248e","name":"admin3645","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/baf40bb2dd82590384e4496ea9a16e5723a6284ec7fb445ad629f19905b6c337?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/baf40bb2dd82590384e4496ea9a16e5723a6284ec7fb445ad629f19905b6c337?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/baf40bb2dd82590384e4496ea9a16e5723a6284ec7fb445ad629f19905b6c337?s=96&d=mm&r=g","caption":"admin3645"},"sameAs":["https:\/\/m2apartners.cz"]}]}},"_links":{"self":[{"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/posts\/5953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/comments?post=5953"}],"version-history":[{"count":1,"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/posts\/5953\/revisions"}],"predecessor-version":[{"id":5955,"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/posts\/5953\/revisions\/5955"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/media\/5524"}],"wp:attachment":[{"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/media?parent=5953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/categories?post=5953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/m2apartners.cz\/en\/wp-json\/wp\/v2\/tags?post=5953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}